aluates Reports

$ 0.0

Automative

Global Pneumococcal Vaccination Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-17P13336

Global Pneumococcal Vaccination Market Research Report 2023

BUY CHAPTERS

Global Pneumococcal Vaccination Market Research Report 2025

Code: QYRE-Auto-17P13336

Report

January 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

MSD

CDIBP

Walvax

Sinovac

Bio Kangtai

Pfizer Inc

GSK

Pneumococcal Vaccination Market Size

The global market for Pneumococcal Vaccination was valued at US$ 9622 million in the year 2024 and is projected to reach a revised size of US$ 19330 million by 2031, growing at a CAGR of 10.6% during the forecast period.

Pneumococcal Vaccination Market

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccination.

The Pneumococcal Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumococcal Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pneumococcal Vaccination Market Report

Report Metric	Details
Report Name	Pneumococcal Vaccination Market
Accounted market size in year	US$ 9622 million
Forecasted market size in 2031	US$ 19330 million
CAGR	10.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	PPSV 23 PCV 13 PCV 10
Segment by Application	Child Adult
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, GSK, MSD, CDIBP, WALVAX, Sinovac, Bio Kangtai
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pneumococcal Vaccination Market growing?

Ans: The Pneumococcal Vaccination Market witnessing a CAGR of 10.6% during the forecast period 2025-2031.

What is the Pneumococcal Vaccination Market size in 2031?

Ans: The Pneumococcal Vaccination Market size in 2031 will be US$ 19330 million.

Who are the main players in the Pneumococcal Vaccination Market report?

Ans: The main players in the Pneumococcal Vaccination Market are Pfizer, GSK, MSD, CDIBP, WALVAX, Sinovac, Bio Kangtai

What are the Application segmentation covered in the Pneumococcal Vaccination Market report?

Ans: The Applications covered in the Pneumococcal Vaccination Market report are Child, Adult

What are the Type segmentation covered in the Pneumococcal Vaccination Market report?

Ans: The Types covered in the Pneumococcal Vaccination Market report are PPSV 23, PCV 13, PCV 10

Recommended Reports

Bacterial Vaccines

Respiratory Vaccines

Pediatric Vaccines

1 Pneumococcal Vaccination Market Overview

1.1 Product Definition

1.2 Pneumococcal Vaccination by Type

1.2.1 Global Pneumococcal Vaccination Market Value Comparison by Type (2024 VS 2031)

1.2.2 PPSV 23

1.2.3 PCV 13

1.2.4 PCV 10

1.3 Pneumococcal Vaccination by Application

1.3.1 Global Pneumococcal Vaccination Market Value by Application (2024 VS 2031)

1.3.2 Child

1.3.3 Adult

1.4 Global Pneumococcal Vaccination Market Size Estimates and Forecasts

1.4.1 Global Pneumococcal Vaccination Revenue 2020-2031

1.4.2 Global Pneumococcal Vaccination Sales 2020-2031

1.4.3 Global Pneumococcal Vaccination Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pneumococcal Vaccination Market Competition by Manufacturers

2.1 Global Pneumococcal Vaccination Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pneumococcal Vaccination Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pneumococcal Vaccination Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pneumococcal Vaccination, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pneumococcal Vaccination, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pneumococcal Vaccination, Product Type & Application

2.7 Global Key Manufacturers of Pneumococcal Vaccination, Date of Enter into This Industry

2.8 Global Pneumococcal Vaccination Market Competitive Situation and Trends

2.8.1 Global Pneumococcal Vaccination Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pneumococcal Vaccination Players Market Share by Revenue

2.8.3 Global Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pneumococcal Vaccination Market Scenario by Region

3.1 Global Pneumococcal Vaccination Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pneumococcal Vaccination Sales by Region: 2020-2031

3.2.1 Global Pneumococcal Vaccination Sales by Region: 2020-2025

3.2.2 Global Pneumococcal Vaccination Sales by Region: 2026-2031

3.3 Global Pneumococcal Vaccination Revenue by Region: 2020-2031

3.3.1 Global Pneumococcal Vaccination Revenue by Region: 2020-2025

3.3.2 Global Pneumococcal Vaccination Revenue by Region: 2026-2031

3.4 North America Pneumococcal Vaccination Market Facts & Figures by Country

3.4.1 North America Pneumococcal Vaccination Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pneumococcal Vaccination Sales by Country (2020-2031)

3.4.3 North America Pneumococcal Vaccination Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pneumococcal Vaccination Market Facts & Figures by Country

3.5.1 Europe Pneumococcal Vaccination Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pneumococcal Vaccination Sales by Country (2020-2031)

3.5.3 Europe Pneumococcal Vaccination Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pneumococcal Vaccination Market Facts & Figures by Region

3.6.1 Asia Pacific Pneumococcal Vaccination Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pneumococcal Vaccination Sales by Region (2020-2031)

3.6.3 Asia Pacific Pneumococcal Vaccination Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Pneumococcal Vaccination Market Facts & Figures by Country

3.7.1 Latin America Pneumococcal Vaccination Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pneumococcal Vaccination Sales by Country (2020-2031)

3.7.3 Latin America Pneumococcal Vaccination Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pneumococcal Vaccination Market Facts & Figures by Country

3.8.1 Middle East and Africa Pneumococcal Vaccination Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pneumococcal Vaccination Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pneumococcal Vaccination Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pneumococcal Vaccination Sales by Type (2020-2031)

4.1.1 Global Pneumococcal Vaccination Sales by Type (2020-2025)

4.1.2 Global Pneumococcal Vaccination Sales by Type (2026-2031)

4.1.3 Global Pneumococcal Vaccination Sales Market Share by Type (2020-2031)

4.2 Global Pneumococcal Vaccination Revenue by Type (2020-2031)

4.2.1 Global Pneumococcal Vaccination Revenue by Type (2020-2025)

4.2.2 Global Pneumococcal Vaccination Revenue by Type (2026-2031)

4.2.3 Global Pneumococcal Vaccination Revenue Market Share by Type (2020-2031)

4.3 Global Pneumococcal Vaccination Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pneumococcal Vaccination Sales by Application (2020-2031)

5.1.1 Global Pneumococcal Vaccination Sales by Application (2020-2025)

5.1.2 Global Pneumococcal Vaccination Sales by Application (2026-2031)

5.1.3 Global Pneumococcal Vaccination Sales Market Share by Application (2020-2031)

5.2 Global Pneumococcal Vaccination Revenue by Application (2020-2031)

5.2.1 Global Pneumococcal Vaccination Revenue by Application (2020-2025)

5.2.2 Global Pneumococcal Vaccination Revenue by Application (2026-2031)

5.2.3 Global Pneumococcal Vaccination Revenue Market Share by Application (2020-2031)

5.3 Global Pneumococcal Vaccination Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Pneumococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Pneumococcal Vaccination Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Pneumococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GSK Pneumococcal Vaccination Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 MSD

6.3.1 MSD Company Information

6.3.2 MSD Description and Business Overview

6.3.3 MSD Pneumococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)

6.3.4 MSD Pneumococcal Vaccination Product Portfolio

6.3.5 MSD Recent Developments/Updates

6.4 CDIBP

6.4.1 CDIBP Company Information

6.4.2 CDIBP Description and Business Overview

6.4.3 CDIBP Pneumococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)

6.4.4 CDIBP Pneumococcal Vaccination Product Portfolio

6.4.5 CDIBP Recent Developments/Updates

6.5 WALVAX

6.5.1 WALVAX Company Information

6.5.2 WALVAX Description and Business Overview

6.5.3 WALVAX Pneumococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)

6.5.4 WALVAX Pneumococcal Vaccination Product Portfolio

6.5.5 WALVAX Recent Developments/Updates

6.6 Sinovac

6.6.1 Sinovac Company Information

6.6.2 Sinovac Description and Business Overview

6.6.3 Sinovac Pneumococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sinovac Pneumococcal Vaccination Product Portfolio

6.6.5 Sinovac Recent Developments/Updates

6.7 Bio Kangtai

6.7.1 Bio Kangtai Company Information

6.7.2 Bio Kangtai Description and Business Overview

6.7.3 Bio Kangtai Pneumococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Bio Kangtai Pneumococcal Vaccination Product Portfolio

6.7.5 Bio Kangtai Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pneumococcal Vaccination Industry Chain Analysis

7.2 Pneumococcal Vaccination Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pneumococcal Vaccination Production Mode & Process Analysis

7.4 Pneumococcal Vaccination Sales and Marketing

7.4.1 Pneumococcal Vaccination Sales Channels

7.4.2 Pneumococcal Vaccination Distributors

7.5 Pneumococcal Vaccination Customer Analysis

8 Pneumococcal Vaccination Market Dynamics

8.1 Pneumococcal Vaccination Industry Trends

8.2 Pneumococcal Vaccination Market Drivers

8.3 Pneumococcal Vaccination Market Challenges

8.4 Pneumococcal Vaccination Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

MSD

CDIBP

Walvax

Sinovac

Bio Kangtai

Pfizer Inc

GSK

List of Tables

Table 1. Global Pneumococcal Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pneumococcal Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pneumococcal Vaccination Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pneumococcal Vaccination Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Pneumococcal Vaccination Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pneumococcal Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pneumococcal Vaccination Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pneumococcal Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pneumococcal Vaccination, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pneumococcal Vaccination, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pneumococcal Vaccination, Product Type & Application

Table 12. Global Key Manufacturers of Pneumococcal Vaccination, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pneumococcal Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccination as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pneumococcal Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pneumococcal Vaccination Sales by Region (2020-2025) & (K Units)

Table 18. Global Pneumococcal Vaccination Sales Market Share by Region (2020-2025)

Table 19. Global Pneumococcal Vaccination Sales by Region (2026-2031) & (K Units)

Table 20. Global Pneumococcal Vaccination Sales Market Share by Region (2026-2031)

Table 21. Global Pneumococcal Vaccination Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pneumococcal Vaccination Revenue Market Share by Region (2020-2025)

Table 23. Global Pneumococcal Vaccination Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pneumococcal Vaccination Revenue Market Share by Region (2026-2031)

Table 25. North America Pneumococcal Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pneumococcal Vaccination Sales by Country (2020-2025) & (K Units)

Table 27. North America Pneumococcal Vaccination Sales by Country (2026-2031) & (K Units)

Table 28. North America Pneumococcal Vaccination Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pneumococcal Vaccination Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pneumococcal Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pneumococcal Vaccination Sales by Country (2020-2025) & (K Units)

Table 32. Europe Pneumococcal Vaccination Sales by Country (2026-2031) & (K Units)

Table 33. Europe Pneumococcal Vaccination Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pneumococcal Vaccination Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pneumococcal Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pneumococcal Vaccination Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Pneumococcal Vaccination Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Pneumococcal Vaccination Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pneumococcal Vaccination Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pneumococcal Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pneumococcal Vaccination Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Pneumococcal Vaccination Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Pneumococcal Vaccination Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pneumococcal Vaccination Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pneumococcal Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pneumococcal Vaccination Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Pneumococcal Vaccination Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Pneumococcal Vaccination Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pneumococcal Vaccination Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pneumococcal Vaccination Sales (K Units) by Type (2020-2025)

Table 51. Global Pneumococcal Vaccination Sales (K Units) by Type (2026-2031)

Table 52. Global Pneumococcal Vaccination Sales Market Share by Type (2020-2025)

Table 53. Global Pneumococcal Vaccination Sales Market Share by Type (2026-2031)

Table 54. Global Pneumococcal Vaccination Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pneumococcal Vaccination Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pneumococcal Vaccination Revenue Market Share by Type (2020-2025)

Table 57. Global Pneumococcal Vaccination Revenue Market Share by Type (2026-2031)

Table 58. Global Pneumococcal Vaccination Price (US$/Unit) by Type (2020-2025)

Table 59. Global Pneumococcal Vaccination Price (US$/Unit) by Type (2026-2031)

Table 60. Global Pneumococcal Vaccination Sales (K Units) by Application (2020-2025)

Table 61. Global Pneumococcal Vaccination Sales (K Units) by Application (2026-2031)

Table 62. Global Pneumococcal Vaccination Sales Market Share by Application (2020-2025)

Table 63. Global Pneumococcal Vaccination Sales Market Share by Application (2026-2031)

Table 64. Global Pneumococcal Vaccination Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pneumococcal Vaccination Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pneumococcal Vaccination Revenue Market Share by Application (2020-2025)

Table 67. Global Pneumococcal Vaccination Revenue Market Share by Application (2026-2031)

Table 68. Global Pneumococcal Vaccination Price (US$/Unit) by Application (2020-2025)

Table 69. Global Pneumococcal Vaccination Price (US$/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer Pneumococcal Vaccination Product

Table 74. Pfizer Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. GSK Pneumococcal Vaccination Product

Table 79. GSK Recent Developments/Updates

Table 80. MSD Company Information

Table 81. MSD Description and Business Overview

Table 82. MSD Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. MSD Pneumococcal Vaccination Product

Table 84. MSD Recent Developments/Updates

Table 85. CDIBP Company Information

Table 86. CDIBP Description and Business Overview

Table 87. CDIBP Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. CDIBP Pneumococcal Vaccination Product

Table 89. CDIBP Recent Developments/Updates

Table 90. WALVAX Company Information

Table 91. WALVAX Description and Business Overview

Table 92. WALVAX Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. WALVAX Pneumococcal Vaccination Product

Table 94. WALVAX Recent Developments/Updates

Table 95. Sinovac Company Information

Table 96. Sinovac Description and Business Overview

Table 97. Sinovac Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Sinovac Pneumococcal Vaccination Product

Table 99. Sinovac Recent Developments/Updates

Table 100. Bio Kangtai Company Information

Table 101. Bio Kangtai Description and Business Overview

Table 102. Bio Kangtai Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Bio Kangtai Pneumococcal Vaccination Product

Table 104. Bio Kangtai Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Pneumococcal Vaccination Distributors List

Table 108. Pneumococcal Vaccination Customers List

Table 109. Pneumococcal Vaccination Market Trends

Table 110. Pneumococcal Vaccination Market Drivers

Table 111. Pneumococcal Vaccination Market Challenges

Table 112. Pneumococcal Vaccination Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pneumococcal Vaccination

Figure 2. Global Pneumococcal Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pneumococcal Vaccination Market Share by Type: 2024 & 2031

Figure 4. PPSV 23 Product Picture

Figure 5. PCV 13 Product Picture

Figure 6. PCV 10 Product Picture

Figure 7. Global Pneumococcal Vaccination Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Pneumococcal Vaccination Market Share by Application: 2024 & 2031

Figure 9. Child

Figure 10. Adult

Figure 11. Global Pneumococcal Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Pneumococcal Vaccination Market Size (2020-2031) & (US$ Million)

Figure 13. Global Pneumococcal Vaccination Sales (2020-2031) & (K Units)

Figure 14. Global Pneumococcal Vaccination Average Price (US$/Unit) & (2020-2031)

Figure 15. Pneumococcal Vaccination Report Years Considered

Figure 16. Pneumococcal Vaccination Sales Share by Manufacturers in 2024

Figure 17. Global Pneumococcal Vaccination Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Pneumococcal Vaccination Players: Market Share by Revenue in Pneumococcal Vaccination in 2024

Figure 19. Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Pneumococcal Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Pneumococcal Vaccination Sales Market Share by Country (2020-2031)

Figure 22. North America Pneumococcal Vaccination Revenue Market Share by Country (2020-2031)

Figure 23. United States Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Pneumococcal Vaccination Sales Market Share by Country (2020-2031)

Figure 26. Europe Pneumococcal Vaccination Revenue Market Share by Country (2020-2031)

Figure 27. Germany Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Pneumococcal Vaccination Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Pneumococcal Vaccination Revenue Market Share by Region (2020-2031)

Figure 34. China Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Pneumococcal Vaccination Sales Market Share by Country (2020-2031)

Figure 44. Latin America Pneumococcal Vaccination Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Pneumococcal Vaccination Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Pneumococcal Vaccination Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Pneumococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Pneumococcal Vaccination by Type (2020-2031)

Figure 54. Global Revenue Market Share of Pneumococcal Vaccination by Type (2020-2031)

Figure 55. Global Pneumococcal Vaccination Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Pneumococcal Vaccination by Application (2020-2031)

Figure 57. Global Revenue Market Share of Pneumococcal Vaccination by Application (2020-2031)

Figure 58. Global Pneumococcal Vaccination Price (US$/Unit) by Application (2020-2031)

Figure 59. Pneumococcal Vaccination Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumonia Vaccine Market Insights Forecast to 2030

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024

Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumococcal Testing Market Research Report 2024

Global Vaccines For Children Market Insights Forecast to 2030

Global Meningococcal Infections Vaccine Market Insights Forecast to 2030

Global Veterinary Vaccination Market Research Report 2025

Global Poliomyelitis Vaccine Market Research Report 2025

Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025

Global Bacterial Vaccines for Humans Market Research Report 2024

Veterinary Vaccine Market

Meningococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Pneumonia Therapeutics Market Research Report 2024

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions